Tagged With "eosinophilic"

Comment

Re: Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

K8sMom2002 ·
Hi, Tomek, You can control the level of emails you receive from our community. Take a moment and update your preferences to see just what you want to see. Hover over your user name and then select "Notifications." If you are on a mobile device, click the menu icon (3 horizontal bars) on the left to pop out the menu. Then click on your user name, then "Notifications." If you are having trouble finding it, use this link . You can choose to be notified of AAFA blog posts, events, when someone...
Comment

Re: Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

Tomek ·
You send out waaaaaaaaay too many emails.
Blog Post

Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

AAFA Community Services ·
The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control New study showed one third of patients had no exacerbations on long-term treatment with Nucala GlaxoSmithKline plc (GSK) today presented new data from the longest study of an anti-IL5 biologic treatment in severe...
Blog Post

FDA Approves Dupixent® for Treatment of Asthma

AAFA Community Services ·
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype and oral corticosteroid-dependent asthma, regardless of phenotype.
Post
×
×
×
×